Live feed16:30:21·169dINSIDERFilingvia QuantisnowChief Financial Officer Frankenfield Christopher James converted options into 19,375 shares and sold $4,522 worth of shares (7,030 units at $0.64), increasing direct ownership by 99% to 24,766 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.XLO· Xilio Therapeutics Inc.Health CareOriginal source
